Morphic presents preclinical data from ΑvΒ8 integrin program at the sitc annual meeting

ΑvΒ8 inhibition demonstrates efficacy in a cancer model refractory to radiation and checkpoint inhibition
MORF Ratings Summary
MORF Quant Ranking